Skip to main content
Log in

Coeliac disease

The debate on coeliac disease screening—are we there yet?

  • News & Views
  • Published:

From Nature Reviews Gastroenterology & Hepatology

View current issue Sign up to alerts

The majority of patients with coeliac disease are undiagnosed, leading to debate about the utility of screening. The heterogeneous clinical presentation, which includes asymptomatic forms, can partially explain the difficulties faced when identifying coeliac disease. Now, Kurppa and colleagues add another element to the debate by strengthening the arguments for general screening.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: A proposal for an updated screening algorithm for coeliac disease in the general population.

References

  1. Kurppa, K. et al. Benefits of a gluten-free diet for asymptomatic patients with serologic markers of celiac disease. Gastroenterology http://dx.doi.org/10.1053/j.gastro.2014.05.003.

  2. Hallert, C. et al. Living with coeliac disease: controlled study of the burden of illness. Scand. J. Gastroenterol. 37, 39–42 (2002).

    Article  CAS  PubMed  Google Scholar 

  3. Størdal, K., Bakken, I. J., Surén, P. & Stene, L. C. Epidemiology of coeliac disease and co-morbidity in Norwegian children. J. Pediatr. Gastroenterol. Nutr. 57, 467–471 (2013).

    Article  PubMed  Google Scholar 

  4. Makharia, G. K. et al. Issues associated with the emergence of coeliac disease in the Asia–Pacific region: a working party report of the World Gastroenterology Organization and the Asian Pacific Association of Gastroenterology. J. Gastroenterol. Hepatol. 29, 666–677 (2014).

    Article  PubMed  Google Scholar 

  5. Sapone, A. et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 10, 13 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Rosén, A. et al. Mass screening for celiac disease from the perspective of newly diagnosed adolescents and their parents: a mixed-method study. BMC Public Health 11, 822 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lionetti, E. et al. Prevalence and natural history of potential celiac disease in at-family-risk infants prospectively investigated from birth. J. Pediatr. 161, 908–914 (2012).

    Article  PubMed  Google Scholar 

  8. Catassi, C. et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann. Med. 42, 530–538 (2010).

    Article  PubMed  Google Scholar 

  9. Alessandrini, S., Giacomoni, E. & Muccioli, F. Mass population screening for celiac disease in children: the experience in Republic of San Marino from 1993 to 2009. Ital. J. Pediatr. 39, 67 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Megiorni, F. et al. HLA-DQ and risk gradient for celiac disease. Hum. Immunol. 70, 55–59 (2009).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlo Catassi.

Ethics declarations

Competing interests

C.C. is a consultant for Dr Schaer and Menarini Diagnostics. A.F. is a co-founder and stock holder in Alba Therapeutics.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Catassi, C., Fasano, A. The debate on coeliac disease screening—are we there yet?. Nat Rev Gastroenterol Hepatol 11, 457–458 (2014). https://doi.org/10.1038/nrgastro.2014.119

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2014.119

  • Springer Nature Limited

This article is cited by

Navigation